Literature DB >> 15848315

Ten year survival after paediatric heart transplantation: a single centre experience.

Rosemary Radley Smith1, Jo Wray, Asghar Khaghani, Magdi Yacoub.   

Abstract

OBJECTIVE: To report 10 years survival in children under the age of 16 years undergoing heart transplantation in a single institution.
METHODS: One hundred and thirty nine/one hundred and ninety three patients (73%) survived more than 1 year after transplant. Seventy four (53%) of these survived more than 10 (10.0-20.1) years. Age at operation was 10 days-15.5 (mean 8.1) years. Patients were maintained on ciclosporin and azathiaprine alone. Routine steroids only given to 4 patients for either persistent rejection or deteriorating renal function. Rejection diagnosed on clinical or echocardiographic grounds. No routine biopsies were performed. Bi-annual coronary angiography was used to diagnose graft coronary disease.
RESULTS: Graft coronary disease was found in 8 patients (11%), 2 were re-transplanted and have survived 4.3-7.2 years since. Two patients are alive without intervention 2.0-13.0 years from initial diagnosis. Two patients have undergone interventional procedures 11 and 16 years after transplantation and are alive 3 and 4 years, respectively, later. Seven patients have had post transplant lymphoproliferative disease (PTLD) and 6 have had no recurrence for 3-13 years after treatment. Impaired renal function with abnormal serum creatinine levels is increasingly common-11 patients have developed end stage renal failure, 7 requiring renal transplantation, hypertension occurred in only 3 patients other than those in renal failure. Late rejection episodes associated with probable non-adherence occurred in 7 patients. There were 10 late deaths; 2 from graft coronary disease; 1 from PTLD; 3 from renal failure; 3 from acute rejection and 1 from infection. Conditional actuarial survival from 1 year post transplant was 76 and 67% at 10 and 15 years, respectively.
CONCLUSIONS: Survival for more than 10 years is increasingly realistic. In this age group adherence and deteriorating renal function are major challenges.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848315     DOI: 10.1016/j.ejcts.2004.12.058

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Steroid avoidance in pediatric heart transplantation results in excellent graft survival.

Authors:  Scott R Auerbach; Jane Gralla; David N Campbell; Shelley D Miyamoto; Biagio A Pietra
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

2.  Outcome of acute graft rejection associated with hemodynamic compromise in pediatric heart transplant recipients.

Authors:  Christina M Phelps; Cecile Tissot; Shannon Buckvold; Jane Gralla; D Dunbar Ivy; Biagio A Pietra; Shelley D Miyamoto
Journal:  Pediatr Cardiol       Date:  2010-10-21       Impact factor: 1.655

3.  Immunosuppression therapy for pediatric heart transplantation.

Authors:  Claire A Irving; Steven A Webber
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-10

4.  Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.

Authors:  Tajinder P Singh; Carey Faber; Elizabeth D Blume; Sarah Worley; Christopher S Almond; Leslie B Smoot; Shay Dillis; Colleen Nasman; Gerard J Boyle
Journal:  J Heart Lung Transplant       Date:  2010-01-12       Impact factor: 10.247

Review 5.  Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.

Authors:  Sangeeta Hingorani
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.